Multiple Sclerosis is a degenerative condition of the central nervous system that affects nearly 2.5 million of individuals in terms of their physical, cognitive, psychological and social capabilities. Despite the high variability of its clinical presentation, relapsing and progressive multiple sclerosis are considered the two main disease types, with the former possibly evolving into the latter. Recently, the attention of the medical community toward the use of patient-centered outcomes in multiple sclerosis has significantly increased. Such patient-friendly measures are devoted to the assessment of the impact of the disease on several domains of the patient life. In this work, we investigate on use of patient-centered outcomes to predict ...
The aim of this work is to predict the disability state in neurodegenerative disease, such as multip...
Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease s...
Background: There is an unmet need for precise methods estimating disease prognosis in multiple scle...
Multiple Sclerosis is a chronic inflammatory disease, affecting the Central Nervous System and leadi...
Multiple sclerosis is an idiopathic inflammatory disease of the central nervous system and the secon...
Background: Achieving an accurate clinical course description in Multiple Sclerosis (MS) is a very h...
The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secon...
Multiple Sclerosis (MS) progresses at an unpredictable rate, but predictions on the disease course i...
Multiple Sclerosis (MS) is a chronic disease that causes the disruption of the ability of the nervou...
Machine learning (ML) applied to patient-reported (PROs) and clinical-assessed outcomes (CAOs) could...
Background and Objectives: Research in Multiple Sclerosis (MS) has recently focused on extracting kn...
Research in Multiple Sclerosis (MS) has recently focused on extracting knowledge from real-world cli...
The aim of this study was to assess the diagnostic accuracy (sensitivity and specificity) of ...
Multiple sclerosis is an incurable chronic inflammatory disease that typically first manifests in ea...
Background: The ability to better predict disease progression represents a major unmet need in multi...
The aim of this work is to predict the disability state in neurodegenerative disease, such as multip...
Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease s...
Background: There is an unmet need for precise methods estimating disease prognosis in multiple scle...
Multiple Sclerosis is a chronic inflammatory disease, affecting the Central Nervous System and leadi...
Multiple sclerosis is an idiopathic inflammatory disease of the central nervous system and the secon...
Background: Achieving an accurate clinical course description in Multiple Sclerosis (MS) is a very h...
The course of multiple sclerosis begins with a relapsing-remitting phase, which evolves into a secon...
Multiple Sclerosis (MS) progresses at an unpredictable rate, but predictions on the disease course i...
Multiple Sclerosis (MS) is a chronic disease that causes the disruption of the ability of the nervou...
Machine learning (ML) applied to patient-reported (PROs) and clinical-assessed outcomes (CAOs) could...
Background and Objectives: Research in Multiple Sclerosis (MS) has recently focused on extracting kn...
Research in Multiple Sclerosis (MS) has recently focused on extracting knowledge from real-world cli...
The aim of this study was to assess the diagnostic accuracy (sensitivity and specificity) of ...
Multiple sclerosis is an incurable chronic inflammatory disease that typically first manifests in ea...
Background: The ability to better predict disease progression represents a major unmet need in multi...
The aim of this work is to predict the disability state in neurodegenerative disease, such as multip...
Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease s...
Background: There is an unmet need for precise methods estimating disease prognosis in multiple scle...